ADISSP
geneOn this page
Also known as FLJ20550
Summary
ADISSP (adipose secreted signaling protein, HGNC:15873) is a protein-coding gene on chromosome 20p13, encoding Adipose-secreted signaling protein (Q9GZN8). Adipocyte-secreted protein (adipokine) that acts as a key regulator for white adipose tissue (WAT) thermogenesis and glucose homeostasis at least in part through activation of protein kinase A (PKA).
Enables protein phosphatase 1 binding activity. Involved in positive regulation of non-canonical NF-kappaB signal transduction and positive regulation of transforming growth factor beta receptor signaling pathway. Predicted to be located in extracellular space.
Source: NCBI Gene 54976 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 11 total — 1 pathogenic
- MANE Select transcript:
NM_001258429
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15873 |
| Approved symbol | ADISSP |
| Name | adipose secreted signaling protein |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20550 |
| Ensembl gene | ENSG00000101220 |
| Ensembl biotype | protein_coding |
| OMIM | 620373 |
| Entrez | 54976 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 protein_coding
ENST00000217195, ENST00000379772, ENST00000399672, ENST00000399683, ENST00000888333, ENST00000888334, ENST00000888335, ENST00000888336, ENST00000888337, ENST00000936143, ENST00000936144, ENST00000936145, ENST00000936146, ENST00000936147, ENST00000948129
RefSeq mRNA: 3 — MANE Select: NM_001258429
NM_001039140, NM_001258429, NM_001258430
CCDS: CCDS33436, CCDS58763
Canonical transcript exons
ENST00000379772 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000657899 | 3754397 | 3754519 |
| ENSE00001482401 | 3760082 | 3760186 |
| ENSE00001814244 | 3767663 | 3767753 |
| ENSE00002994527 | 3758536 | 3758678 |
| ENSE00003152408 | 3755469 | 3755607 |
| ENSE00003903109 | 3753508 | 3754158 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 98.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 53.7162 / max 3421.2063, expressed in 1821 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 186167 | 50.4550 | 1821 |
| 186168 | 2.9614 | 1447 |
| 186166 | 0.2997 | 116 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| nucleus accumbens | UBERON:0001882 | 98.45 | gold quality |
| caudate nucleus | UBERON:0001873 | 98.07 | gold quality |
| putamen | UBERON:0001874 | 97.56 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.95 | gold quality |
| granulocyte | CL:0000094 | 96.36 | gold quality |
| right ovary | UBERON:0002118 | 95.72 | gold quality |
| left uterine tube | UBERON:0001303 | 95.59 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.28 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.26 | gold quality |
| lower esophagus | UBERON:0013473 | 95.25 | gold quality |
| left ovary | UBERON:0002119 | 95.01 | gold quality |
| decidua | UBERON:0002450 | 94.18 | gold quality |
| monocyte | CL:0000576 | 94.14 | gold quality |
| leukocyte | CL:0000738 | 94.05 | gold quality |
| mononuclear cell | CL:0000842 | 94.05 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.70 | gold quality |
| cingulate cortex | UBERON:0003027 | 93.63 | gold quality |
| omental fat pad | UBERON:0010414 | 93.51 | gold quality |
| peritoneum | UBERON:0002358 | 93.45 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 93.21 | gold quality |
| body of uterus | UBERON:0009853 | 93.14 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.82 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 92.77 | gold quality |
| right uterine tube | UBERON:0001302 | 92.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.04 | gold quality |
| amygdala | UBERON:0001876 | 91.92 | gold quality |
| apex of heart | UBERON:0002098 | 91.79 | gold quality |
| hypothalamus | UBERON:0001898 | 91.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.69 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 131.17 |
| E-MTAB-10287 | yes | 100.67 |
| E-MTAB-6678 | yes | 26.73 |
| E-CURD-122 | yes | 10.88 |
| E-CURD-112 | yes | 10.31 |
| E-CURD-88 | yes | 8.96 |
| E-MTAB-9801 | yes | 7.96 |
| E-ANND-3 | yes | 7.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
42 targeting ADISSP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-6126 | 99.62 | 68.09 | 996 |
| HSA-MIR-4708-3P | 99.51 | 67.99 | 870 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-324-3P | 99.26 | 66.31 | 1034 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ADISSP | ENSDARG00000076239 |
| danio_rerio | adissp | ENSDARG00000087426 |
| mus_musculus | Adissp | ENSMUSG00000027327 |
| rattus_norvegicus | Adissp | ENSRNOG00000021245 |
| drosophila_melanogaster | CG6983 | FBGN0035896 |
Protein
Protein identifiers
Adipose-secreted signaling protein — Q9GZN8 (reviewed: Q9GZN8)
All UniProt accessions (2): Q9GZN8, H7BYU9
UniProt curated annotations — full annotation on UniProt →
Function. Adipocyte-secreted protein (adipokine) that acts as a key regulator for white adipose tissue (WAT) thermogenesis and glucose homeostasis at least in part through activation of protein kinase A (PKA).
Subcellular location. Secreted.
Similarity. Belongs to the ADISSP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9GZN8-1 | 1 | yes |
| Q9GZN8-2 | 2 |
RefSeq proteins (3): NP_001034229, NP_001245358, NP_001245359 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026794 | ADISSP | Family |
Pfam: PF15006
UniProt features (6 total): modified residue 2, initiator methionine 1, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZN8-F1 | 80.45 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 2, 147
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 150 (showing top):
RNGTGGGC_UNKNOWN, VERHAAK_AML_WITH_NPM1_MUTATED_DN, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, CMYB_01, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION
GO Biological Process (5): obsolete positive regulation of protein kinase A signaling (GO:0010739), positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511), glucose homeostasis (GO:0042593), positive regulation of non-canonical NF-kappaB signal transduction (GO:1901224), adaptive thermogenesis (GO:1990845)
GO Molecular Function (1): protein phosphatase 1 binding (GO:0008157)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), cellular_component (GO:0005575), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transforming growth factor beta receptor signaling pathway | 1 |
| regulation of transforming growth factor beta receptor signaling pathway | 1 |
| positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 |
| positive regulation of cellular response to transforming growth factor beta stimulus | 1 |
| carbohydrate homeostasis | 1 |
| non-canonical NF-kappaB signal transduction | 1 |
| regulation of non-canonical NF-kappaB signal transduction | 1 |
| positive regulation of intracellular signal transduction | 1 |
| temperature homeostasis | 1 |
| protein phosphatase binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
414 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ADISSP | DMWD | Q09019 | 627 |
| ADISSP | SEC24C | P53992 | 595 |
| ADISSP | BRK1 | Q8WUW1 | 594 |
| ADISSP | HIP1R | O75146 | 577 |
| ADISSP | JCAD | Q9P266 | 552 |
| ADISSP | SWAP70 | Q9UH65 | 548 |
| ADISSP | CPNE1 | Q99829 | 528 |
| ADISSP | TOR4A | Q9NXH8 | 518 |
| ADISSP | PCYT2 | Q99447 | 513 |
| ADISSP | TPM3 | P06753 | 474 |
| ADISSP | ATG3 | Q9NT62 | 441 |
| ADISSP | PSME3 | P61289 | 376 |
| ADISSP | QSER1 | Q2KHR3 | 376 |
| ADISSP | HEBP1 | Q9NRV9 | 370 |
| ADISSP | ATAD3B | Q5T9A4 | 357 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PPP1CA | PPP1CC | psi-mi:“MI:0914”(association) | 0.850 |
| PPP1CB | CCDC85C | psi-mi:“MI:0914”(association) | 0.750 |
| PPP1CC | CCDC85C | psi-mi:“MI:0914”(association) | 0.740 |
| PPP1CA | CCDC85C | psi-mi:“MI:0914”(association) | 0.670 |
| PPP1CA | PQBP1 | psi-mi:“MI:0914”(association) | 0.510 |
| PPP1R7 | CCDC85C | psi-mi:“MI:0914”(association) | 0.510 |
| ADISSP | rep | psi-mi:“MI:0915”(physical association) | 0.370 |
| PHKB | ADISSP | psi-mi:“MI:0915”(physical association) | 0.370 |
| ADISSP | RALYL | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP1CC | RPLP2 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP1CA | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| FAM133A | DNM1L | psi-mi:“MI:0914”(association) | 0.350 |
| EPB41L5 | LIN7A | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM69 | ACOX3 | psi-mi:“MI:0914”(association) | 0.350 |
| ARHGEF7 | ACOX3 | psi-mi:“MI:0914”(association) | 0.350 |
| PCDHGA9 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP1CC | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP1CA | ADISSP | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPP1CB | ADISSP | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPP1R7 | ADISSP | psi-mi:“MI:0915”(physical association) | 0.000 |
| FERMT2 | ADISSP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (49): C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Two-hybrid), RALYL (Two-hybrid), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS)
ESM2 similar proteins: A6QLH6, B0KWT6, B1MTV8, B2GV38, B2KIK3, B5X9S9, B5XFI8, B7NZQ9, C1BGZ8, C9J798, O09172, O14908, O43374, O70422, P0CL18, P11441, P21126, P41214, P48507, P48508, P60027, Q0P5I8, Q2T9Y6, Q2TBN5, Q32LP0, Q3B7U9, Q58CR3, Q5R4T1, Q5R812, Q5RA63, Q5RB75, Q5RCR8, Q5ZMQ0, Q66H91, Q68FF6, Q7ZWB2, Q8BPA8, Q8IVD9, Q8R1T1, Q8WUX9
Diamond homologs: B5FX50, Q2KIM1, Q4KM45, Q68FA2, Q9D1K7, Q9GZN8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3024618 | GRCh37/hg19 20p13-12.1(chr20:68351-16142323)x3 | Pathogenic |
SpliceAI
1094 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:3754154:CCGGT:C | acceptor_gain | 1.0000 |
| 20:3754155:CGGT:C | acceptor_gain | 1.0000 |
| 20:3754155:CGGTC:C | acceptor_gain | 1.0000 |
| 20:3754156:GGT:G | acceptor_gain | 1.0000 |
| 20:3754156:GGTC:G | acceptor_loss | 1.0000 |
| 20:3754157:GT:G | acceptor_gain | 1.0000 |
| 20:3754157:GTCT:G | acceptor_loss | 1.0000 |
| 20:3754158:TCT:T | acceptor_loss | 1.0000 |
| 20:3754159:C:CC | acceptor_gain | 1.0000 |
| 20:3754160:T:C | acceptor_loss | 1.0000 |
| 20:3754324:C:A | donor_gain | 1.0000 |
| 20:3754388:CG:C | donor_gain | 1.0000 |
| 20:3754516:TAAC:T | acceptor_gain | 1.0000 |
| 20:3754525:C:T | acceptor_gain | 1.0000 |
| 20:3755464:CGCA:C | donor_loss | 1.0000 |
| 20:3755465:GCACC:G | donor_loss | 1.0000 |
| 20:3755466:CACCT:C | donor_loss | 1.0000 |
| 20:3758533:TA:T | donor_loss | 1.0000 |
| 20:3758534:A:C | donor_loss | 1.0000 |
| 20:3758535:CCT:C | donor_gain | 1.0000 |
| 20:3758537:TTG:T | donor_gain | 1.0000 |
| 20:3758538:TG:T | donor_gain | 1.0000 |
| 20:3758561:T:A | donor_gain | 1.0000 |
| 20:3758675:TTGC:T | acceptor_gain | 1.0000 |
| 20:3758676:TGC:T | acceptor_gain | 1.0000 |
| 20:3758676:TGCCT:T | acceptor_loss | 1.0000 |
| 20:3758677:GC:G | acceptor_gain | 1.0000 |
| 20:3758678:CC:C | acceptor_gain | 1.0000 |
| 20:3758679:C:CA | acceptor_loss | 1.0000 |
| 20:3758679:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
1148 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:3754140:G:T | P148H | 1.000 |
| 20:3755599:G:C | F57L | 1.000 |
| 20:3755599:G:T | F57L | 1.000 |
| 20:3755600:A:G | F57S | 1.000 |
| 20:3755601:A:G | F57L | 1.000 |
| 20:3754122:A:T | V154D | 0.999 |
| 20:3754141:G:A | P148S | 0.999 |
| 20:3754141:G:T | P148T | 0.999 |
| 20:3754146:C:T | G146D | 0.999 |
| 20:3754402:A:T | V140D | 0.999 |
| 20:3755580:A:G | Y64H | 0.999 |
| 20:3755597:A:G | L58P | 0.999 |
| 20:3755597:A:T | L58Q | 0.999 |
| 20:3755600:A:C | F57C | 0.999 |
| 20:3755601:A:C | F57V | 0.999 |
| 20:3755603:C:T | G56D | 0.999 |
| 20:3755604:C:G | G56R | 0.999 |
| 20:3758540:A:T | V53D | 0.999 |
| 20:3758576:A:T | V41D | 0.999 |
| 20:3758602:A:C | F32L | 0.999 |
| 20:3758602:A:T | F32L | 0.999 |
| 20:3758604:A:G | F32L | 0.999 |
| 20:3754064:A:C | F173L | 0.998 |
| 20:3754064:A:T | F173L | 0.998 |
| 20:3754066:A:G | F173L | 0.998 |
| 20:3754134:A:G | L150P | 0.998 |
| 20:3754134:A:T | L150Q | 0.998 |
| 20:3754140:G:C | P148R | 0.998 |
| 20:3754146:C:A | G146V | 0.998 |
| 20:3754147:C:A | G146C | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000211955 (20:3764666 C>T), RS1000267308 (20:3757914 G>A), RS1000416166 (20:3760083 C>T), RS1000752640 (20:3758747 C>G,T), RS1000812809 (20:3753114 C>T), RS1000814833 (20:3764388 A>G), RS1000851654 (20:3765383 G>C), RS1000917430 (20:3765112 G>C), RS1001224735 (20:3756647 G>A), RS1001416511 (20:3761383 T>C), RS1001601261 (20:3768008 G>A), RS1001716844 (20:3756472 G>A), RS1001879886 (20:3759195 C>G,T), RS1001907358 (20:3767029 C>A), RS1001968795 (20:3768175 C>T)
Disease associations
OMIM: gene MIM:620373 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002822_12 | Survival in colon cancer | 7.000000e-06 |
| GCST003075_23 | Cognitive decline rate in late mild cognitive impairment | 6.000000e-07 |
| GCST003075_62 | Cognitive decline rate in late mild cognitive impairment | 7.000000e-07 |
| GCST004602_228 | Mean corpuscular volume | 3.000000e-12 |
| GCST90002392_80 | Mean corpuscular volume | 6.000000e-38 |
| GCST90002396_49 | Mean reticulocyte volume | 8.000000e-16 |
| GCST90002397_445 | Mean spheric corpuscular volume | 7.000000e-39 |
| GCST90002398_52 | Neutrophil count | 1.000000e-10 |
| GCST90002403_310 | Red blood cell count | 8.000000e-09 |
| GCST90002405_439 | Reticulocyte count | 6.000000e-10 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0000409 | disease free survival |
| EFO:0007710 | cognitive decline measurement |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0004833 | neutrophil count |
| EFO:0004305 | erythrocyte count |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 3 |
| cobaltous chloride | decreases expression | 2 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| ICG 001 | increases expression | 1 |
| jinfukang | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Copper | affects binding, decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Selenium | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | decreases expression, affects cotreatment | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Vitamin E | affects cotreatment, decreases expression, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2TA | Abcam HEK293T C20orf27 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): colonic neoplasm